Your session is about to expire
← Back to Search
Virtual Care Transition for COPD (TELE-TOC Trial)
N/A
Waitlist Available
Led By Valerie G Press, MD, MPH
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 -days
Awards & highlights
TELE-TOC Trial Summary
This trial will evaluate if virtual visits can improve care transitions for COPD patients, reducing hospital readmissions and medication safety events.
Who is the study for?
This trial is for adults aged 40 or older who have been hospitalized with a COPD exacerbation and are part of the COPD Hospital Readmission Reduction Program. It's designed to help those at high risk for readmission and medication issues.Check my eligibility
What is being tested?
The study tests a telehealth intervention called TELE-TOC, which includes virtual visits and pharmacy-based in-home support after hospital discharge, aiming to improve medication use and health outcomes in COPD patients.See study design
What are the potential side effects?
Since this trial focuses on education and telehealth services rather than medications, there are no direct side effects like you'd expect from drugs. However, technical issues or miscommunication could potentially occur.
TELE-TOC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 180 -days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 -days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Correct inhaler technique 30 days post discharge
Reach of the TELE-TOC intervention
Secondary outcome measures
180 day revisits
30 day revisits
90 day revisits
+3 moreTELE-TOC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TELE-TOC plus Usual CareExperimental Treatment6 Interventions
Patients randomized to this arm will receive the TELE-TOC intervention as well as the standard COPD care via the institution's COPD readmission reduction program.
Group II: Usual CareActive Control4 Interventions
Patients randomized to this arm will receive standard COPD care via the institution's COPD readmission reduction program.
Find a Location
Who is running the clinical trial?
Society of Hospital MedicineOTHER
5 Previous Clinical Trials
23,954 Total Patients Enrolled
COPD FoundationOTHER
17 Previous Clinical Trials
238,114 Total Patients Enrolled
Washington University School of MedicineOTHER
1,935 Previous Clinical Trials
2,299,607 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am younger than 40 years old.I am over 40 and hospitalized for a COPD flare-up.I am currently in the intensive care unit.
Research Study Groups:
This trial has the following groups:- Group 1: TELE-TOC plus Usual Care
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Could any more individuals still be enrolled in this clinical investigation?
"According to clinicaltrials.gov, this particular study is no longer accepting patients at the current time; initially posted on October 1st 2023 and last updated in May of that same year. Fortunately, there are 34 other medical trials recruiting volunteers now."
Answered by AI
What is the ultimate aim of this clinical trial?
"The primary aim of this experiment, to be judged after 30 days post discharge, is the successful implementation of TELE-TOC. Secondary outcomes are 90 day revisits (percentage of patients with an ED visit or readmission within 90 days), 180 day revisits (proportion of patients requiring emergency care/readmission in quarter two) and medication errors (number of mistakes at the time TELE-TOC was administered)."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger